Pawan Virendra Rawal, MBBS

Pawan Rawal practices at Tri-state Neurology in Memphis, Tennessee.

Pawan Rawal's NPI, 1255659009, was assigned on May 4, 2010. Pawan Rawal holds Tennessee license 53007.

Pawan Rawal's primary practice is Tri-state Neurology, at 5100 Sanderlin Ave Suite 2100 Suite 2100, Memphis, TN 38117-4387. The practice phone is (901) 820-0141.

Pawan Rawal's primary practice is Tri-state Neurology in Memphis, Tennessee. Pawan Rawal is also affiliated with Methodist University Hospital. The medical group on file is Tri-State Neurology. Dmand AI also links Pawan Rawal to 5 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pawan Rawal practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Pawan Rawal's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Pawan Rawal is licensed in Tennessee.

CMS data shows 32,749 Medicare services from Pawan Rawal across 25 procedure codes in 2024, for 906 Medicare patients. Medicare paid $1,689,541 for them.

CMS counts 906 Medicare patients who saw Pawan Rawal in 2024. The largest group is 75 to 84, with 344 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Pawan Rawal's median patient age at 68, with 59% women.

In 2024, Pawan Rawal wrote 2,689 Medicare Part D claims for 323 patients. 87% of them were for generic drugs. CMS names the drug for 2,473 of them, across 51 drugs with 11 or more claims each, at $550,998 in total drug cost. In 2023, CMS named 1,987 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Pawan Rawal for performance year 2024, reported as part of a group. Pawan Rawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Pawan Rawal as offering telehealth.

Dmand AI links 12 papers to Pawan Rawal, published from 2013 to 2018. 2013 was the busiest year, with 3. The most frequent topics are Brain Ischemia, Fibrinolytic Agents and Stroke. Pawan Rawal has published most often in J Stroke Cerebrovasc Dis. Pawan Rawal's most frequent co-authors are Andrei V. Alexandrov, MD, Niren Kapoor, MBBS, PhD and Michael J. Lyerly.

CMS Open Payments shows 673 general payments to Pawan Rawal from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Supernus Pharmaceuticals, Inc. paid the most, $3,962.